Postdoctoral ResearcherNew York UniversityAstoria, New York, United States
Disclosure information not submitted.
In situ Transglutaminase 2-mediated Crosslinking of Engineered IL-7 to the Tumor Matrix Enhances Immunotherapy and Anti-PD-1 Response
Thursday, April 16, 202610:30 AM - 10:45 AM US ET